Neutrophil Extracellular Traps (NETs) in health and disease
By the time reflux becomes noticeable, the early nausea has usually settled
Germany GLP-1 Receptor Agonist Market Trends Germany is the best GLP-1 receptor agonist market in Europe, with an estimated USD 1.9 billion in 2025 due to a high prevalence of diabetes (approximately 8.5 million cases constituting 10.2% of the population), a well-developed healthcare system, and somewhat favorable reimbursement conditions
The platforms ability to prescribe both brand-name GLP-1s and compounded alternatives, plus oral weight-loss options, gives clinicians maximum flexibility to tailor treatment
Because Lilly is investing heavily in capacity, oral medicines, and pipeline expansion, investors will be watching whether gross margin and operating leverage remain clean as the company scales
Members reported their weight at initial intake and at regular intervals thereafter